-
EP2905030
European procedure
Extract from the Register of European Patents
EP About this file: EP2905030
| EP2905030 - Human antibodies that bind lymphocyte activation gene-3 (LAG-3) and uses thereof [Right-click to bookmark this link] | Status | The patent has been granted Status updated on 04.10.2019 Database last updated on 26.04.2025 | |
| Former | Grant of patent is intended Status updated on 19.05.2019 | ||
| Former | Examination is in progress Status updated on 11.02.2017 | Most recent event Tooltip | 15.04.2024 | Change: Date of oral proceedings | 15.04.2024 | Deletion: Despatch of minutes of oral proceedings | Applicant(s) | For all designated states E. R. Squibb & Sons, L.L.C. Route 206 & Province Line Road Princeton, NJ 08540 / US | [2015/33] | Inventor(s) | 01 /
Thudium, Kent B. 700 Bay Road Redwood City, CA 94063 / US | 02 /
Korman, Alan J. 700 Bay Road Redwood City, CA 94063 / US | 03 /
Leblanc, Heidi 700 Bay Road Redwood City, CA 94063 / US | 04 /
Yamanaka, Mark 2953 Amoroso Court Pleasanton, CA 94566 / US | 05 /
Selby, Mark 700 Bay Road Redwood City, CA 94063 / US | 06 /
Zens, Kyra, D. 521 Cottonwood Drive Milpitas, CA 95035 / US | [2015/36] | Representative(s) | Mewburn Ellis LLP Aurora Building Counterslip Bristol BS1 6BX / GB | [N/P] |
| Former [2015/33] | Reitstötter Kinzebach Patentanwälte Sternwartstrasse 4 81679 München / DE | Application number, filing date | 15156647.8 | 11.08.2009 | [2015/33] | Priority number, date | US20080188548P | 11.08.2008 Original published format: US 188548 P | [2015/33] | Filing language | EN | Procedural language | EN | Publication | Type: | A1 Application with search report | No.: | EP2905030 | Date: | 12.08.2015 | Language: | EN | [2015/33] | Type: | B1 Patent specification | No.: | EP2905030 | Date: | 06.11.2019 | Language: | EN | [2019/45] | Search report(s) | (Supplementary) European search report - dispatched on: | EP | 13.07.2015 | Classification | IPC: | A61K39/00, C07K17/00, A61K39/395, A61K51/10, C07K16/28 | [2015/33] | CPC: |
C07K16/2803 (EP,CN,IL,KR,US);
A61P31/12 (EP,IL);
A61P31/18 (EP,IL);
A61P35/00 (EP,IL,KR);
A61P35/02 (EP,IL);
A61P37/00 (EP,IL);
A61P37/04 (EP,IL);
A61P43/00 (EP,IL);
C07K16/2827 (EP,IL,US);
A61K2039/505 (EP,IL,KR,US);
A61K2039/507 (EP,IL,US);
C07K2317/21 (EP,IL,KR,US);
C07K2317/33 (KR);
C07K2317/34 (EP,IL,US);
C07K2317/73 (EP,IL,KR,US);
| Designated contracting states | AT, BE, BG, CH, CY, CZ, DE, DK, EE, ES, FI, FR, GB, GR, HR, HU, IE, IS, IT, LI, LT, LU, LV, MC, MK, MT, NL, NO, PL, PT, RO, SE, SI, SK, SM, TR [2016/11] |
| Former [2015/33] | AT, BE, BG, CH, CY, CZ, DE, DK, EE, ES, FI, FR, GB, GR, HR, HU, IE, IS, IT, LI, LT, LU, LV, MC, MK, MT, NL, NO, PL, PT, RO, SE, SI, SK, SM, TR | Title | German: | Lymphozytenaktivierungsgen-3 (LAG-3) bindende humane Antikörper und ihre Verwendung | [2015/33] | English: | Human antibodies that bind lymphocyte activation gene-3 (LAG-3) and uses thereof | [2015/33] | French: | Anticorps humains qui se lient à l'activation des lymphocytes gène-3 (lag-3) et leurs utilisations | [2015/33] | Examination procedure | 09.02.2016 | Amendment by applicant (claims and/or description) | 09.02.2016 | Examination requested [2016/11] | 13.10.2016 | Despatch of a communication from the examining division (Time limit: M06) | 21.04.2017 | Reply to a communication from the examining division | 20.09.2017 | Despatch of a communication from the examining division (Time limit: M06) | 29.03.2018 | Reply to a communication from the examining division | 26.09.2018 | Despatch of a communication from the examining division (Time limit: M02) | 05.12.2018 | Reply to a communication from the examining division | 20.05.2019 | Communication of intention to grant the patent | 26.09.2019 | Fee for grant paid | 26.09.2019 | Fee for publishing/printing paid | 26.09.2019 | Receipt of the translation of the claim(s) | Parent application(s) Tooltip | EP09807162.4 / EP2320940 | Divisional application(s) | EP19186310.9 / EP3597216 | EP22185991.1 / EP4147714 | Opposition(s) | Opponent(s) | 01
05.08.2020
18.08.2020
ADMISSIBLE Regeneron Pharmaceuticals, Inc. 777 Old Saw Mill River Road Tarrytown NY 10591 / US Opponent's representative Hoffmann Eitle Patent- und Rechtsanwälte PartmbB Arabellastraße 30 81925 München / DE | [2020/39] | 25.08.2020 | Invitation to proprietor to file observations on the notice of opposition | 04.03.2021 | Reply of patent proprietor to notice(s) of opposition | 13.09.2022 | Date of oral proceedings | 04.10.2022 | Despatch of interlocutory decision in opposition | 04.10.2022 | Despatch of minutes of oral proceedings | Appeal following opposition | 02.12.2022 | Appeal received No. T2552/22 | 02.12.2022 | Payment of appeal fee | 14.02.2023 | Statement of grounds filed | 09.12.2022 | Appeal received No. T2552/22 | 09.12.2022 | Payment of appeal fee | 13.02.2023 | Statement of grounds filed | 13.05.2025 | Date of oral proceedings | Fees paid | Renewal fee | 26.02.2015 | Renewal fee patent year 03 | 26.02.2015 | Renewal fee patent year 04 | 26.02.2015 | Renewal fee patent year 05 | 26.02.2015 | Renewal fee patent year 06 | 10.08.2015 | Renewal fee patent year 07 | 11.08.2016 | Renewal fee patent year 08 | 14.08.2017 | Renewal fee patent year 09 | 10.08.2018 | Renewal fee patent year 10 | 15.08.2019 | Renewal fee patent year 11 |
| Opt-out from the exclusive Tooltip competence of the Unified Patent Court | See the Register of the Unified Patent Court for opt-out data | ||
| Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court. | Documents cited: | Search | [XAI]WO9110682 (INST NAT SANTE RECH MED [FR], et al); | [XYI]WO9530750 (ROUSSY INST GUSTAVE [FR], et al); | [XYI]WO9703695 (APPLIED RESEARCH SYSTEMS [AN], et al); | [XYI]US6197524 (ROMAGNANI SERGIO [IT]); | by applicant | US4399216 | US4439196 | US4447233 | US4447224 | US4475196 | US4486194 | US4487603 | US4522811 | EP0154316 | US4596556 | US4634665 | WO8704462 | US4790824 | WO8901036 | US4816567 | EP0338841 | US4941880 | EP0401384 | US5064413 | WO9203918 | US5179017 | WO9312227 | US5223409 | US5225539 | US5312335 | WO9425585 | US5374548 | WO9429351 | US5383851 | US5399163 | US5399331 | US5403484 | US5416016 | US5427908 | US5476996 | US5530101 | US5545806 | US5545807 | US5569825 | US5571698 | US5580717 | US5585089 | WO9713852 | US5624821 | US5625126 | US5633425 | US5648260 | US5661016 | US5677425 | US5693762 | US5698767 | US5714350 | US5760185 | US5762905 | WO9824884 | US5770429 | US5789650 | US5811097 | US5814318 | WO9842752 | US5833943 | US5837243 | US5869046 | US5874299 | US5877397 | US5885793 | US5922845 | US5939598 | WO9945962 | US5969108 | WO9954342 | US6075181 | WO0037504 | US6090382 | WO0042072 | US6114598 | US6121022 | US6150584 | US6156313 | US6162963 | US6165745 | US6172197 | US6180370 | WO0109187 | US6194551 | WO0114424 | US6207156 | US6277375 | EP1176195 | US6350861 | WO0243478 | WO02092780 | WO02092812 | WO02096910 | US2002199213 | US6521404 | US6544731 | US6555313 | WO03035835 | US6582915 | US6593081 | US2003153043 | WO03074679 | US2004110704 | US6794132 | US6818216 | US6827925 | US6914128 | US2005153394 | US6951646 | US2006004081 | US6989452 | US2006024317 | US7087600 | WO2006089231 | US7129261 | US2006247295 | WO2006121168 | WO2007005874 | WO2007038658 | WO2007051081 | WO2007059404 | WO2008083312 | WO2008103693 | WO2009045957 | WO2009054863 | WO2009073533 | WO2009073546 | Opposition | WO9530750 | EP0758383 | US5874250 | US5976877 | US6197524 | WO0243478 | US6808710 | US2006083744 | WO2006121168 | WO2010019570 | US10358495 |